News
SEATTLE, March 5, 2025 /PRNewswire/ — Magnolia Medical Technologies, Inc., the pioneer in Initial Specimen Diversion Device ® (ISDD ®) technology, today announced groundbreaking new findings from an ...
New Study Demonstrates Potential for Enhanced Accuracy of Blood Cultures with Steripath® Initial Specimen Diversion Device® (ISDD®) for Central Line DrawsSEATTLE, March 5, 2025 /PRNewswire/ -- ...
Initial Specimen Diversion Device utilization mitigates blood culture contamination across regional community hospital and acute care facility. Am J Med Qual. 2022;37 (5):405-412. doi: 10.1097/JMQ ...
Magnolia Medical Technologies, Inc., the pioneer in Initial Specimen Diversion Device® (ISDD®) technology, today announced groundbreaking new findings from an in-vitro study demonstrating that ...
SEATTLE, March 5, 2025 /PRNewswire/ -- Magnolia Medical Technologies, Inc., the pioneer in Initial Specimen Diversion Device ® (ISDD ®) technology, today announced groundbreaking new findings from an ...
Zimmerman FS, Assous MV, Zevin S, Wiener-Well Y. Reducing blood culture contamination using an Initial Specimen Diversion Device. Am J Infect Control. 2019;47 (7):822-826. 1016/j.2018.12.004.
Steripath Micro is the only low-diversion volume blood culture collection device family with a specific FDA 510 (k)-cleared indication to reduce blood culture contamination. 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results